Skip to main content
Bulletin of the National Research Centre

Table 4 The pharmacological characteristics drug scores and toxicity risks for molecule 1, designed molecules (1a–1c), and Sofosbuvir as reference inhibitor (R)

From: In silico design and pharmacokinetics investigation of some novel hepatitis C virus NS5B inhibitors: pharmacoinformatics approach

Back to article page